Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:21 03/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11.77 HKD | -0.51% |
|
+1.47% | -1.67% |
| 11:07am | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 02/09 | Roche, Simcere Pharma Strike Drug Licensing Deal | DJ |
| Market Cap | 385.55Cr 3.02TCr 331.72Cr 311.3Cr 284.81Cr 531.58Cr 36TCr 535.79Cr 3.68TCr 1.43TCr 19TCr 1.45TCr 1.42TCr 60TCr | P/E 2026 * |
14.7x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 365.82Cr 2.87TCr 314.75Cr 295.37Cr 270.24Cr 504.38Cr 35TCr 508.37Cr 3.49TCr 1.36TCr 18TCr 1.37TCr 1.34TCr 57TCr | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.2x |
| Free-Float |
32.13% | Yield 2026 * |
3.57% | Yield 2027 * | 4.06% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
Deutsche Boerse AG
| S2P | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
OTC Markets
| SMHGF | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | -0.51% | ||
| 1 week | +1.47% | ||
| Current month | +6.04% | ||
| 1 month | -4.70% | ||
| 3 months | +17.82% | ||
| 6 months | -0.51% | ||
| Current year | -1.67% |
| 1 week | 10.96 |  | 11.9 |
| 1 month | 10.96 | | 12.82 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.55 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Other | Chairperson | -30,00,000 | 0.1168% | ||
| 13/07/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/07/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | +1.47% | -9.53% | +92.64% | 387.42Cr | |
| -0.81% | +0.14% | +21.37% | +72.78% | 4.91TCr | |
| +0.41% | +0.12% | +52.20% | +121.38% | 4.04TCr | |
| -0.97% | -3.88% | +13.37% | +84.21% | 1.22TCr | |
| -1.28% | -1.78% | -11.64% | +12.58% | 1.21TCr | |
| +0.57% | +0.95% | +29.02% | +153.11% | 914.24Cr | |
| +0.08% | -4.12% | +24.01% | +43.45% | 735.61Cr | |
| -0.04% | -0.04% | +22.68% | +222.92% | 734.89Cr | |
| +0.81% | -0.04% | +45.87% | -10.06% | 731.57Cr | |
| +0.03% | -1.75% | -40.80% | +14.39% | 518.8Cr | |
| Average | -0.17% | -0.05% | +14.65% | +80.74% | 1.54TCr | |
| Weighted average by Cap. | -0.27% | +0.41% | +25.16% | +86.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150.12Cr 1.18TCr 129.17Cr 121.21Cr 110.9Cr 206.99Cr 14TCr 208.63Cr 1.43TCr 558.42Cr 7.25TCr 563.75Cr 551.45Cr 23TCr | 169.21Cr 1.33TCr 145.59Cr 136.62Cr 125Cr 233.3Cr 16TCr 235.15Cr 1.62TCr 629.4Cr 8.17TCr 635.41Cr 621.55Cr 26TCr |
| Net income | 26Cr 200.13Cr 22Cr 21Cr 19Cr 35Cr 2.41TCr 35Cr 243.81Cr 95Cr 1.23TCr 96Cr 94Cr 3.97TCr | 30Cr 236.52Cr 26Cr 24Cr 22Cr 42Cr 2.85TCr 42Cr 288.14Cr 112.21Cr 1.46TCr 113.28Cr 110.81Cr 4.69TCr |
| Net Debt | -20Cr -154.69Cr -17Cr -16Cr -15Cr -27Cr -1.87TCr -27Cr -188.46Cr -73Cr -953.17Cr -74Cr -72Cr -3.07TCr | -14Cr -109.56Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -19Cr -133.47Cr -52Cr -675.08Cr -52Cr -51Cr -2.17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | HK$11.77 | -0.51% | 68,69,000 |
| 02/26/02 | HK$11.83 | +7.64% | 1,47,37,000 |
| 01/26/01 | HK$10.99 | -0.99% | 43,55,000 |
| 31/26/31 | HK$11.10 | -1.77% | 77,03,000 |
| 28/26/28 | HK$11.30 | -1.82% | 47,26,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
